Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00332488 · ClinicalTrials.gov registry record · Phase 3
Efficacy and Safety of Prandial Inhalation of Technosphere/Insulin in Combination With Metformin or Technosphere/Insulin Alone Versus 2 Oral Anti-Diabetic Agents in Subjects With Type 2 Diabetes
A Phase 3 study, sponsored by Mannkind Corporation.
- Completed
- Registry status
- Phase 3
- Development phase
- 547
- Enrollment target
NCT00332488 is a Phase 3 study that has completed, run by Mannkind Corporation. The registered enrollment target is 547 participants.
The verdict
NCT00332488, a Phase 3 study, has completed, sponsored by Mannkind Corporation.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 547 participants
- Enrollment target
Study Summary
to demonstrate the efficacy of inhaled Technosphere/Insulin in combination with metformin versus combination metformin and a secretagogue
Interventions
- DRUG Technosphere Insulin
- DRUG Metformin & Secretagogues
- DRUG Technosphere Insulin & Metformin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 547 participants |
| Start Date | 2004-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00332488
The ClinicalTrials.gov registry entry for NCT00332488 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 547 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mannkind Corporation, which has 42 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Technosphere Insulin is the first listed.
NCT00332488 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00332488 about?
NCT00332488 is a clinical study titled "Efficacy and Safety of Prandial Inhalation of Technosphere/Insulin in Combination With Metformin or Technosphere/Insulin Alone Versus 2 Oral Anti-Diabetic Agents in Subjects With Type 2 Diabetes". to demonstrate the efficacy of inhaled Technosphere/Insulin in combination with metformin versus combination metformin and a secretagogue
What is the current status of trial NCT00332488?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 547 participants. The study started on 2004-12.
What interventions are being tested in trial NCT00332488?
The interventions under investigation include: Technosphere Insulin (DRUG), Metformin & Secretagogues (DRUG), Technosphere Insulin & Metformin (DRUG).
Who is sponsoring clinical trial NCT00332488?
This trial is sponsored by Mannkind Corporation, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.